Peptide record

TPDB45169

Antiviral standard
22 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45169
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 22-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
YGRKKRRQRRRPGDVYANGLVA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C112H190N44O29
CEHIMFSTW
R
2617.02
12.12
8
1
7
+7
4.65
-1.586
53.18
Mammalian: 2.8 hour Yeast: 10 min E.coli: 2 min
2980
1.14
4
Residue Composition
number
2
A
6
R
1
N
1
D
0
C
0
E
1
Q
3
G
0
H
0
I
1
L
2
K
0
M
0
F
1
P
0
S
0
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 2 R: 6 N: 1 D: 1 C: 0 E: 0 Q: 1 G: 3 H: 0 I: 0 L: 1 K: 2 M: 0 F: 0 P: 1 S: 0 T: 0 W: 0 Y: 2 V: 2
Chemical Descriptors
22 reviewed residue count
C112H190N44O29 sequence-only estimate (linear, free termini)
2617.02 sequence-only estimate (linear, free termini)
12.12 sequence-only estimate (linear, free termini)
+7 sequence-only estimate (linear, free termini)
4.65 sequence-only estimate (linear, free termini)
-1.586 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA